TABLE 2.
Transmission reduction from antibody-deficient immunized mice
| Mouse strain | Donor immunization | No. of infected BALB/c donors at day 4/total no. of donors (mean titer ± SEM) |
No. of infected CFW contacts/total no. of contacts (mean titer ± SEM) |
% Reduction in transmission vs B/NP-rAd | ||||
|---|---|---|---|---|---|---|---|---|
| Lung (log10TCID50/mL) | Nasal wash (Log10TCID50/mL) | Total (%) | Lung (log10TCID50/mL) | Nasal wash (Log10TCID50/mL) | Total (%) | |||
| BALB/c | A/NP+M2-rAd | 1/16 (2.45) | 4/16 (2.51 ± 0.06) | 5/16 (31.3) | 1/24 (2.45) | 0/24 | 1/24 (4.2) | 95.2 (P < 0.001) |
| B/NP-rAd | 16/16 (6.27 ± 0.11) | 16/16 (3.77 ± 0.17) | 16/16 (100) | 9/24 (4.95 ± 0.54) | 21/24 (3.89 ± 0.24) | 21/24 (87.5) | ||
| mIgTg-JHD−/− | A/NP+M2-rAd | 20/22 (4.44 ± 0.32) | 20/22 (3.10 ± 0.12) | 22/22 (100) | 0/33 | 0/33 | 0/33 (0) | 100 (P < 0.001) |
| B/NP-rAd | 22/22 (6.00 ± 0.22) | 22/22 (4.28 ± 0.17) | 22/22 (100) | 7/33 (4.15 ± 0.44) | 15/33 (3.36 ± 0.19) | 18/33 (54.6) | ||